文献速递骨软组织肉瘤与黑色素瘤

深度学习用于软组织肉瘤诊断与生存预测

Deep learning for diagnosis and survival prediction in soft tissue sarcoma.
PubMed 文献 · Ann Oncol · 2021-06-15

这项回顾性多中心研究纳入291例软组织肉瘤患者的506张组织病理切片,以TCGA队列(240例)为训练验证集、另一多中心队列(51例)为测试集,评估深度学习模型(DLM)的诊断与预后预测价值。DLM诊断五种常见亚型的平均AUROC为0.97,并将九位病理医师的准确率从46.3%提升至87.1%;在平滑肌肉瘤中预测疾病特异性生存状态的AUROC为0.91。

要点

  • DLM诊断五种常见STS亚型平均AUROC 0.97、准确率79.9%。
  • DLM使病理医师诊断准确率由46.3%升至87.1%且更快更确定。
  • LMS中DLM预测生存AUROC 0.91,为独立预后因素(P=0.008)。

核心结论

  • 深度学习可基于常规组织病理切片准确诊断常见STS亚型。
  • DLM或可用于最常见亚型LMS的预后预测。
  • DLM可帮助病理医师更快、更准确地作出诊断。

研究设计与样本

  • 回顾性、多中心研究,共纳入291例STS患者的506张组织病理切片。
  • TCGA队列240例作为训练与验证集。
  • 另一多中心队列51例作为额外测试集。
  • 由九位不同经验水平的病理医师评估DLM作为临床决策支持系统的价值。
  • 预后预测使用85例平滑肌肉瘤患者的139张切片。

主要发现

  • DLM诊断五种最常见STS亚型的平均AUROC为0.97(±0.01),准确率为79.9%(±6.1%)。
  • DLM使病理医师准确率由46.3%(±15.5%)显著提升至87.1%(±11.1%)。
  • 病理医师使用DLM后诊断显著更快且更确定。
  • LMS中预测疾病特异性生存状态的平均AUROC为0.91(±0.1),准确率88.9%(±9.9%)。
  • Cox回归显示DLM预测为显著独立预后因素(P=0.008,HR 5.5,95%CI 1.56-19.7),优于其他风险因素。

临床怎么用

  • 可将DLM作为病理诊断的临床决策支持工具,辅助识别常见STS亚型。
  • 在LMS中可结合DLM预测结果进行预后分层。
  • DLM辅助有望提升病理医师诊断速度与信心,改善STS临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical management of soft tissue sarcoma (STS) is particularly challenging. Here, we used digital pathology and deep learning (DL) for diagnosis and prognosis prediction of STS. PATIENTS AND METHODS: Our retrospective, multicenter study included a total of 506 histopathological slides from 291 patients with STS. The Cancer Genome Atlas cohort (240 patients) served as training and validation set. A second, multicenter cohort (51 patients) served as an additional test set. The use of the DL model (DLM) as a clinical decision support system was evaluated by nine pathologists with different levels of expertise. For prognosis prediction, 139 slides from 85 patients with leiomyosarcoma (LMS) were used. Area under the receiver operating characteristic (AUROC) and accuracy served as main outcome measures. RESULTS: The DLM achieved a mean AUROC of 0.97 (±0.01) and an accuracy of 79.9% (±6.1%) in diagnosing the five most common STS subtypes. The DLM significantly improved the accuracy of the pathologists from 46.3% (±15.5%) to 87.1% (±11.1%). Furthermore, they were significantly faster and more certain in their diagnosis. In LMS, the mean AUROC in predicting the disease-specific survival status was 0.91 (±0.1) and the accuracy was 88.9% (±9.9%). Cox regression showed the DLM's prediction to be a significant independent prognostic factor (P = 0.008, hazard ratio 5.5, 95% confidence interval 1.56-19.7) in these patients, outperforming other risk factors. CONCLUSIONS: DL can be used to accurately diagnose frequent subtypes of STS from conventional histopathological slides. It might be used for prognosis prediction in LMS, the most prevalent STS subtype in our cohort. It can also help pathologists to make faster and more accurate diagnoses. This could substantially improve the clinical management of STS patients.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Foersch S, Eckstein M, Wagner DC, et al. Deep learning for diagnosis and survival prediction in soft tissue sarcoma. Ann Oncol. 2021. PMID: 34139273. doi:10.1016/j.annonc.2021.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。